Sarka Forejtova

Sarka Forejtova

Auto-generated profile, based on publicly available information

Sarka Forejtova

Institute of Rheumatology, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2012 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
RVRonald F. van Vollenhoven
Ronald F. van Vollenhoven
RFRoy Fleischmann
Roy Fleischmann
SCStanley Cohen
Stanley Cohen
ELEun Bong Lee
Eun Bong Lee
JMJuan A. García Meijide
Juan A. García Meijide
BWBethanie Wilkinson
Bethanie Wilkinson
Tofacitinib (CP-690,550) is a novel oral Janus kinase inhibitor that is being investigated for the treatment of rheumatoid arthritis.

1 October 2005 in Spine
Verified
Journal Article
Closed access
STSo Tsukahara
So Tsukahara
NMNobuhiko Miyazawa
Nobuhiko Miyazawa
HAHiroyuki Akagawa
Hiroyuki Akagawa
SFSarka Forejtova
Sarka Forejtova
Karel PavelkaKarel Pavelka
Karel Pavelka
IIIturo Inoue
Ituro Inoue
Genetic screening of collagen 6A1 gene (COL6A1) in patients with diffuse idiopathic skeletal hyperostosis (DISH) recruited in Japan and the Czech Republic. To investigate allelic associations between DISH and nucleotide variants of COL6A1. DISH is a skeletal hyperostotic disease characterized by ligamentous ossification of the anterolateral side of the spine. Ossification of the posterior longitudinal ligament (OPLL) is a related disorder with DISH, and COL6A1 was identified as a susceptibility gene to OPLL. COL6A1 was examined for susceptibility in DISH patients from Japan and the Czech Republic. Seven single nucleotide polymorphisms of COL6A1 were genotyped by direct sequencing. The allele frequencies were compared between 97 Japanese DISH patients and 298 Japanese controls, and between 96 Czech DISH patients and 96 Czech controls by χ2 test. The intron 32 (−29) single nucleotide polymorphisms of COL6A1 was significantly associated with the Japanese DISH patients (χ2 = 9.33; P = 0.0022), but not with the Czech DISH patients. Because COL6A1 could be a susceptibility to the occurrence of DISH and OPLL in the Japanese population, we consider that COL6A1 could be responsible for the hyperostotic state, leading to ectopic bone formation in the spinal ligament.

1 April 2004 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
Karel PavelkaKarel Pavelka
Karel Pavelka
ŠFŠ. Forejtová
Š. Forejtová
MOM. Olejárová
M. Olejárová
JGJ. Gatterová
J. Gatterová
LŠLadislav Šenolt
Ladislav Šenolt
APA. Pavelková
A. Pavelková

15 September 2015 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
JHJana Hurnakova
Jana Hurnakova
JZJakub Zavada
Jakub Zavada
PHPetra Hanova
Petra Hanova
HHHana Hulejova
Hana Hulejova
MKMartin Klein
Martin Klein
LŠLadislav Šenolt
Ladislav Šenolt
Calprotectin, a heterodimeric complex of S100A8/9 (MRP8/14), has been proposed as an important serum biomarker that reflects disease activity and structural joint damage in rheumatoid arthritis (RA). The objective of this cross-sectional study was to test the hypothesis that calprotectin is associated with clinical and ultrasound-determined disease activity in patients with RA. A total of 37 patients with RA (including 24 females, a mean disease duration of 20 months) underwent a clinical examination and 7-joint ultrasound score (German US-7) of the clinically dominant hand and foot to assess synovitis by grey-scale (GS) and synovial vascularity by power Doppler (PD) ultrasound using semiquantitative 0–3 grading. The levels of serum calprotectin and C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were determined at the time of the ultrasound assessment. We analysed the relationship between serum calprotectin level, traditional inflammatory markers, and ultrasound-determined synovitis. The levels of serum calprotectin were significantly correlated with swollen joint count (r = 0.465, p < 0.005), DAS28-ESR (r = 0.430, p < 0.01), ESR (r = 0.370, p < 0.05) and, in particular, CRP (r = 0.629, p < 0.001). Calprotectin was significantly associated with GS (r = 0.359, p < 0.05) and PD synovitis scores (r = 0.497, p < 0.005). Using multivariate regression analysis, calprotectin, adjusted for age and sex, was a better predictor of PD synovitis score (R2 = 0.765, p < 0.001) than CRP (R2 = 0.496, p < 0.001). The serum levels of calprotectin are significantly associated with clinical, laboratory and ultrasound assessments of RA disease activity. These results suggest that calprotectin might be superior to CRP for monitoring ultrasound-determined synovial inflammation in RA patients.

1 June 2005 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
LŠLadislav Šenolt
Ladislav Šenolt
MBMartin Braun
Martin Braun
MOM Olejárová
M Olejárová
ŠFŠ Forejtová
Š Forejtová
JGJ Gatterová
J Gatterová
Karel PavelkaKarel Pavelka
Karel Pavelka
Background: Pentosidine, an advanced glycation end product, increasingly accumulates in articular cartilage with age, and contributes to the pathogenesis of osteoarthritis (OA). Increased pentosidine concentrations are associated with inflammatory disorders—for example, rheumatoid arthritis. Objective: To compare pentosidine serum concentrations in patients with knee OA and in healthy volunteers and to determine a relationship between pentosidine and cartilage oligomeric matrix protein (COMP)—a marker of articular cartilage destruction. Methods: Paired serum and synovial fluid samples were obtained by arthrocentesis from 38 patients with knee OA and from 38 healthy volunteers. Pentosidine concentration was measured by reverse phase high performance liquid chromatography with fluorescent detection and COMP was determined by sandwich ELISA. Results: Significantly increased serum pentosidine (p<0.01) and COMP (p<0.05) levels were detected in the patients with OA compared with the control group. Serum pentosidine correlated significantly with synovial fluid pentosidine (p<0.001). Pentosidine in synovial fluid (p<0.05) and in serum (p<0.05) correlated significantly with synovial fluid COMP. Pentosidine and COMP concentrations did not correlate significantly with the radiological stage of the disease. Conclusion: Increased pentosidine serum concentration in patients with OA and its correlation with the cartilage destruction marker COMP in synovial fluid suggests that pentosidine may be important in OA pathology and is a new potential OA marker.

1 January 2012 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
LŠLadislav Šenolt
Ladislav Šenolt
HHH Hulejova
H Hulejova
OKO Krystufkova
O Krystufkova
SFS Forejtova
S Forejtova
LCL Andres Cerezo
L Andres Cerezo
JVJ Vencovsky
J Vencovsky
Objective Dickkopf-1 (DKK-1) is an inhibitor of osteoblastogenesis, and its lower levels are linked to new bone formation. The aim of this study was therefore to explore serum levels of DKK-1 and to evaluate DKK-1's association with the severity of spinal involvement in diffuse idiopathic skeletal hyperostosis (DISH). Methods Serum levels of total and functional DKK-1 and C-reactive protein (CRP) were measured in 37 patients with DISH and 22 healthy age and sex-matched controls. Plain radiographs of the cervical and thoracic spine were performed, and the diagnosis of DISH was defined using the Resnick criteria. Patients were divided into three groups based on spinal involvement. Bone mineral density (BMD) and bone turnover markers were evaluated in patients with DISH. Results The levels of total serum DKK-1 were significantly lower in patients with DISH than in healthy controls (p<0.0001). Importantly, low serum levels of DKK-1 were associated with more severe spinal involvement in DISH, independent of age, sex, disease duration, CRP, bone turnover markers or BMD. However, these findings were less significant for functional DKK-1. Conclusion These observations indicate that DKK-1 may play a significant role in bone formation during DISH.